ClinicalTrials.gov record

Terminated Not applicable Interventional Accepts healthy volunteers Results available

Influenza Vaccine Post Allogeneic Transplant

ClinicalTrials.gov ID: NCT01215981

Public ClinicalTrials.gov record NCT01215981. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 14, 2026, 2:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

MT2010-08R Influenza Vaccine Specific Immune Responses After Allogeneic Hematopoietic Cell Transplantation: Are One or Two Vaccine Doses Needed?

Study identification

NCT ID: NCT01215981
Recruitment status: Terminated
Study type: Interventional
Phase: Not applicable
Lead sponsor: Masonic Cancer Center, University of Minnesota; Other
Enrollment: 68 participants

Conditions and interventions

Conditions

Interventions

Influenza vaccine Biological

Biological

Eligibility (public fields only)

Age range: 6 Months and older
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Aug 31, 2010
Primary completion: May 31, 2011
Completion: May 31, 2011
Last update posted: Dec 27, 2017

2010 – 2011

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
Masonic Cancer Center, University of Minnesota	Minneapolis	Minnesota	55455	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01215981, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Dec 27, 2017 · Synced May 14, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01215981 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →